From correspondents in Maharashtra, India, 10:46 PM IST
RMS Regrow, India’s leading cell therapy services companyhas launched its first cell therapy laboratory in Lonavala, in the state of Maharashtra. It was inaugurated by the Guest of HonourMr. Dong Yern Kim, the Consul General of South Korea today at the ceremony heldat Shah Industrial estate, Nagargaon.
Presentat the occasion were Dr. K. H. Sancheti - Founder of Sancheti Institute as Chief Guest, Dr. Cheong-Ho-Chang,CEO & Chairman, Sewon Cellontech, South Korea asChief Patron along with Mr. Satyen Sanghavi, Chief Scientific Officer, RMSRegrow. The event witnessed the presence of prominent personalities and expertsfrom the healthcare and medical industry such as Dr. Seok Jung Kim from South Korea.Dr. N C Arora, Dr. Dinshaw Pardiwala and Dr. Nilesh Shah.
Expressinghis views on the occasion, Mr. Dong YernKim, Consul General of South Korea said,”It is indeed a pleasure andhonour to be present at the inauguration ceremony today. The RMS lab will playa significant role in the medical and pharmaceutical sector and provide beststem cell therapies in India.India has emerged as adestination for innovative medical services and we are happy to have a technologicalcollaboration between Indiaand Korea.”
Addingmore insights on Stem Cell Therapy, Dr.K. H. Sancheti - Founder of SanchetiInstitute said, “I would like to congratulate Mr. YashSanghavi and Mr. Satyen Sanghavi for taking up this initiative of re-growth andwish that their efforts go a long way in India and abroad. I have alwayssupported people who work towards growth and development of mankind, and so itis a pleasure to be at the inauguration.”
Dr. Cheong-Ho-Chang, CEO & Chairman,Sewon Cellontech, South Korea exclaimed that, “RMS Regrow is ourprecious partner and we wish to improve our technologies through their supportand provide the best services in the field of regenerative medicine in India.The mission of RMS is not only to bring newer technologies to doctors but tobring hope to the patients who need the treatments.”
Outliningthe progress and journey of RMS Regrow, Mr.Satyen Sanghavi, Chief Scientific Officer said “We wish to redefine the currenttreatments available in stem cell therapy and initiate the application of thesetherapies to hospitals and doctors for the fast and improved recovery forcartilage and bone repair. With the launch of RMS Regrow - India’s first stem cell therapylaboratory, we see our dream taking a shape towards reality.”
Realizingthe growing need and awareness of the Cell Therapy in India, RMS Regrow along with SewonCellontech decided to set up an autologous cell therapy laboratory inLonavala. RMS lab is the only facilityin Indiathat provides cell culturing and application services for regeneration ofCartilage & Bone cells. With the launch of these therapies, patients cannow get affordable treatment and easy access to medical assistance by reducingtheir overall cost by 1/4th of what they would incur abroad.
RMS labwill facilitate Cartilage regenerationtherapy - Chondron™ and Boneregeneration therapy -Ossron™.Chondron™ can enable prevention of early Osteoarthritis & finallyavoid Total Knee Replacement. RMSRegrow will enable patients, particularly youngsters & sports personnel toresume their active life without being marred or setback by the defects incartilage due to their strenuous activities. Ossron™ will avoid endurance ofcomplex, painful Hip ReplacementSurgeries arises due to Bone necrosis or other bone defects due to cancer& non-union fractures. Patients can look positively towards increasing thelife longevity by more than 20 years.
Strategically placed in Lonavala, the lab is easily accessible fromMumbai and Pune, two major cities of India. Based on the Technologytransfer from Sewon Cellontech, S. Korea,the entire processing & quality control of the cell based therapies hasbeen designed & constructed in accordance with Good Manufacturing Practice(GMP) / Good Laboratory Practice (GLP) standards.
Most Recent Comments
View all comments »